Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)
|
|
|
- Cd26
- Dpp4
- Ffar1
- Ffar4
- Gcg
- Gpr119
- Gpr120
- Gpr40
- Grp
- Lep
- O3far1
- Ob
|
|
Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)
|
|
|
- Cd26
- Dpp4
- Ffar1
- Gip
- Gpr119
- Gpr40
|
|
Synthesis of diphthamide-EEF2
|
|
|
|
|
Reelin signalling pathway
|
|
|
- Dab1
- Fyn
- Reln
- Ruk
- Seta
- Sh3kbp1
- Vldlr
|
|
PCP/CE pathway
|
|
|
- Arha
- Arha2
- Daam1
- Dvl1
- Dvl2
- Dvl3
- Fzd1
- Fzd3
- Fzd6
- Fzd7
- LOC100361515
- Pfn1
- Rac
- Rac1
- Rac2
- Rhoa
- Wnt-4
- Wnt-5a
- Wnt1
- Wnt11
- Wnt4
- Wnt5a
- Wnt5b
|
|
Regulated proteolysis of p75NTR
|
|
|
- Adam17
- Aph1a
- Ncstn
- Ngfr
- Ps2
- Psen1
- Psen2
- Psenen
- Psnl1
- Psnl2
- Tace
- Tnfrsf16
|
|
Synaptic adhesion-like molecules
|
|
|
- Dlg1
- Dlg3
- Dlg4
- Dlgh1
- Dlgh3
- Dlgh4
- Flot1
- Flot2
- GluA1
- GluA3
- GluN2D
- Glur1
- Glur3
- Glur4
- Gria1
- Gria3
- Gria4
- Grin1
- Grin2a
- Grin2b
- Grin2c
- Grin2d
- Lar
- Lrfn1
- Lrfn2
- Lrfn3
- Lrfn4
- Nmdar1
- Psd95
- Ptprd
- Ptprf
- Ptprs
- Reg1
- Reg2
- Rtn3
- Salm1
- Salm2
- Salm3
- Salm4
|
|
Release of Hh-Np from the secreting cell
|
|
|
- Dhh
- Disp2
- Gpc5
- Ihh
- Notum
- Scube2
- Shh
- Vhh-1
|
|
Attenuation phase
|
|
|
- Cbp
- Crebbp
- Dnajb1
- Ep300
- Fkbp4
- Fkbp52
- Hsbp1
- Hsc70
- Hsc73
- Hsf1
- Hsp70-1
- Hsp70-2
- Hsp70-3
- Hsp84
- Hsp86
- Hsp90aa1
- Hsp90ab1
- Hspa1
- Hspa1a
- Hspa1b
- Hspa1l
- Hspa2
- Hspa8
- Hspc3
- Hspca
- Hspcb
- Hst70
- Ptges3
- Tebp
|
|
Synthesis of glycosylphosphatidylinositol (GPI)
|
|
|
- Dpm2
- Piga
- Pigb
- Pigc
- Pigf
- Pigg
- Pigh
- Pigl
- Pigm
- Pign
- Pigp
- Pigq
- Pigv
- Pigw
- Pigx
|
|
O-linked glycosylation
|
|
|
- Ago61
- B3galnt2
- Dag1
- Gtdc2
- Gyltl1b
- Large1
- Large2
- Pomgnt1
- Pomgnt2
- Pomk
- Pomt1
- Pomt2
- Sgk196
|
|
cGMP effects
|
- Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A
- Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B
- High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A
- Inositol 1,4,5-triphosphate receptor associated 1
- Inositol 1,4,5-trisphosphate-gated calcium channel ITPR1
- Phosphodiesterase
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
- cGMP-dependent 3',5'-cyclic phosphodiesterase
- cGMP-dependent protein kinase 2
- cGMP-dependent protein kinase
- cGMP-specific 3',5'-cyclic phosphodiesterase
|
|
- AABR07006724.1
- Insp3r
- Irag1
- Itpr1
- Mrvi1
- Pde10a
- Pde11a
- Pde1a
- Pde1b
- Pde1b1
- Pde2a
- Pde5
- Pde5a
- Pde9a
- Prkg1
- Prkg2
|
|
Thyroxine biosynthesis
|
|
|
- Cga
- Cga1
- Dehal1
- Duox1
- Duox2
- Iyd
- Lnox2
- Nis
- Slc5a5
- Thox2
- Tpo
- Tshb
|
|
Negative feedback regulation of MAPK pathway
|
|
|
- Braf
- Erk1
- Erk2
- Map2k1
- Map2k2
- Mapk
- Mapk1
- Mapk3
- Mek1
- Mek2
- Mkk2
- Prkm1
- Prkm3
- Prkmk1
- Prkmk2
- Raf
- Raf1
|
|
MAPK1 (ERK2) activation
|
|
|
- Erk2
- Il-6
- Il6
- Il6r
- Il6ra
- Il6st
- Jak1
- Jak2
- Map2k2
- Mapk
- Mapk1
- Mek2
- Mkk2
- Prkm1
- Prkmk2
- Ptpn11
- Tyk2
|
|
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
|
|
|
- ENSRNOG00000067007
- Ikbkg
- Irak1
- Irak2
- Jnk1
- Jnk2
- Jnk3
- Map2k4
- Map2k7
- Map3k7
- Map3k7ip2
- Mapk10
- Mapk8
- Mapk9
- Nemo
- Nod1
- Nod2
- Prkm10
- Prkm8
- Prkm9
- Ripk2
- Tab1
- Tab2
- Tab3
- Traf6
|
|
ERKs are inactivated
|
|
|
- Bmk1
- Dusp3
- Dusp4
- Dusp6
- Dusp7
- Erk1
- Erk2
- Erk5
- Mapk
- Mapk1
- Mapk3
- Mapk7
- Mkp2
- Mkp3
- Mkpx
- Ppp2ca
- Ppp2cb
- Ppp2r1a
- Ppp2r1b
- Ppp2r5d
- Prkm1
- Prkm3
- Vrk3
|
|
SUMOylation of immune response proteins
|
|
|
- Ikba
- Ikbke
- Ikbkg
- Nemo
- Nfkb2
- Nfkbia
- Pias3
- Pias4
- Rela
- Sumo1
- Sumo3
- Topors
- Ubce9
- Ube2i
|
|
Negative regulation of MET activity
|
|
|
- Ash
- Cbl
- Eps15
- Grb2
- Hgf
- Hgs
- Hrs
- Hrs2
- LOC100360645
- Lrig1
- Met
- Ptpn1
- Ptpn2
- Ptprj
- Rps27a
- Ruk
- Seta
- Sh3d2a
- Sh3d2c1
- Sh3gl1
- Sh3gl2
- Sh3gl3
- Sh3kbp1
- Sh3p13
- Sh3p4
- Sh3p8
- Stam
- Stam2
- Uba80
- Ubb
- Ubbl1
- Ubc
- Ubcep1
- Ubcl1
- Usp8
|
|
Negative regulation of FGFR2 signaling
|
|
|
- Ash
- Cbl
- Erk1
- Erk2
- FGF22
- FGF6
- Fgf-1
- Fgf-2
- Fgf-5
- Fgf-7
- Fgf-9
- Fgf1
- Fgf10
- Fgf16
- Fgf17
- Fgf18
- Fgf2
- Fgf20
- Fgf22
- Fgf23
- Fgf3
- Fgf4
- Fgf5
- Fgf5c
- Fgf5d
- Fgf6
- Fgf7
- Fgf7a
- Fgf7b
- Fgf8
- Fgf9
- Fgfa
- Fgfr2
- Frs2
- Grb2
- Kgf
- LOC100360645
- Mapk
- Mapk1
- Mapk3
- Prkm1
- Prkm3
- Ptpn11
- Rps27a
- Uba80
- Ubb
- Ubbl1
- Ubc
- Ubcep1
- Ubcl1
|
|
Negative regulation of FGFR1 signaling
|
|
|
- Ash
- Cbl
- Erk1
- Erk2
- FGF22
- FGF6
- Fgf-1
- Fgf-2
- Fgf-5
- Fgf-9
- Fgf1
- Fgf10
- Fgf17
- Fgf2
- Fgf20
- Fgf22
- Fgf23
- Fgf3
- Fgf4
- Fgf5
- Fgf5c
- Fgf5d
- Fgf6
- Fgf7a
- Fgf7b
- Fgf8
- Fgf9
- Fgfa
- Fgfr1
- Flg
- Frs2
- Grb2
- Kl
- LOC100360645
- Mapk
- Mapk1
- Mapk3
- Prkm1
- Prkm3
- Ptpn11
- Rps27a
- Uba80
- Ubb
- Ubbl1
- Ubc
- Ubcep1
- Ubcl1
|
|
Negative regulation of FGFR3 signaling
|
|
|
- Ash
- Cbl
- Erk1
- Erk2
- Fgf-1
- Fgf-2
- Fgf-5
- Fgf-9
- Fgf1
- Fgf16
- Fgf17
- Fgf18
- Fgf2
- Fgf20
- Fgf23
- Fgf4
- Fgf5
- Fgf7a
- Fgf8
- Fgf9
- Fgfa
- Fgfr3
- Frs2
- Grb2
- LOC100360645
- Mapk
- Mapk1
- Mapk3
- Prkm1
- Prkm3
- Ptpn11
- Rps27a
- Uba80
- Ubb
- Ubbl1
- Ubc
- Ubcep1
- Ubcl1
|
|
Negative regulation of FGFR4 signaling
|
|
|
- Ash
- Cbl
- Erk1
- Erk2
- FGF15
- FGF6
- Fgf-1
- Fgf-2
- Fgf-9
- Fgf1
- Fgf16
- Fgf17
- Fgf18
- Fgf19
- Fgf2
- Fgf20
- Fgf23
- Fgf4
- Fgf6
- Fgf7a
- Fgf7b
- Fgf8
- Fgf8a
- Fgf9
- Fgfa
- Fgfr4
- Frs2
- Grb2
- Klb
- LOC100360645
- Mapk
- Mapk1
- Mapk3
- Prkm1
- Prkm3
- Ptpn11
- Rps27a
- Uba80
- Ubb
- Ubbl1
- Ubc
- Ubcep1
- Ubcl1
|
|
TGF-beta receptor signaling activates SMADs
|
|
|
- Cbl
- Fkbp1
- Fkbp1a
- Fur
- Furin
- Itga8
- Itgav
- Itgb1
- Itgb3
- Itgb5
- Itgb6
- Itgb8
- Ltbp1
- Ltbp2
- Ltbp3
- Ltbp4
- Madh2
- Madh3
- Madh4
- Nedd8
- Pcsk3
- Smad2
- Smad3
- Smad4
- Tgf-b3
- Tgfb1
- Tgfb2
- Tgfb3
- Tgfbr1
- Tgfbr2
- Tgfbr3
- Ube2m
- Zfyve9
|
|
Regulation of KIT signaling
|
|
|
- Aps
- Ash
- Cbl
- Fyn
- Grb2
- KIT
- Kit
- Kitl
- Kitlg
- Lck
- Lyn
- Mgf
- Pkca
- Prkca
- Ptph6
- Ptpn6
- Sh2b2
- Sos1
- Src
- Yes1
|
|